Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 138th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
RLAY	RELAY THERAPEUTICS INC	$696.07M	-44.20%	-39.50%	-43.73%	-46.50%	0.11	19.96	100.00%	-4,341.50%	-4,341.53%
MGTX	MEIRAGTX HOLDINGS PLC	$589.68M	-315.60%	-63.50%	-99.57%	-76.00%	66.13	0.88	26.60%	-415.40%	-381.52%
GALT	GALECTIN THERAPEUTICS INC	$288.27M	N/A	-226.00%	-694.90%	-50.60%	-1.12	1.43	N/A	N/A	N/A
KROS	KEROS THERAPEUTICS INC	$631.57M	3.00%	2.70%	3.72%	61.90%	0.07	21.11	100.00%	8.10%	11.55%
TSHA	TAYSHA GENE THERAPIES INC	$823.84M	-79.90%	-45.70%	-30.08%	-175.00%	0.34	12.48	100.00%	-1,145.00%	-1,143.96%
RYTM	RHYTHM PHARMACEUTICALS INC	$6.38B	-1,884.80%	-49.70%	-66.25%	-95.90%	-20.08	2.79	89.20%	-120.50%	-103.12%
ALGS	ALIGOS THERAPEUTICS INC	$57.64M	-123.90%	-66.80%	-53.70%	-107.30%	0.32	6.31	100.00%	-2,337.20%	-1,936.36%
AGEN	AGENUS INC	$141.80M	N/A	-78.00%	168.15%	-1,029.80%	-1.47	0.06	99.40%	-162.90%	-81.58%
ARDX	ARDELYX INC	$1.57B	-36.60%	-13.40%	-10.28%	-9.00%	2.35	4.30	84.80%	-14.60%	-10.25%
SEER	SEER INC	$114.93M	-25.90%	-23.20%	-26.45%	-25.40%	0.12	19.15	49.90%	-506.20%	-504.64%
NVAX	NOVAVAX INC	$1.31B	-142.30%	28.70%	47.97%	117.00%	34.52	2.36	88.30%	39.20%	42.13%
HRTX	HERON THERAPEUTICS INC	$189.18M	N/A	-3.40%	-3.60%	-1.80%	-9.29	2.40	74.00%	-5.20%	-3.57%
PVLA	PALVELLA THERAPEUTICS INC	$604.19M	-58.40%	-40.60%	-31.83%	371.60%	0.54	7.67	100.00%	50,203.80%	38,513.21%
XNCR	XENCOR INC	$605.53M	-25.70%	-18.40%	-17.20%	-13.80%	0.42	5.34	100.00%	-116.40%	-91.72%
STOK	STOKE THERAPEUTICS INC	$1.28B	18.30%	15.50%	11.73%	30.70%	0.15	6.98	100.00%	26.30%	20.30%
LEGN	LEGEND BIOTECH CORP	$6.25B	-30.90%	-19.40%	-19.89%	-40.60%	0.63	4.71	62.50%	-40.80%	-35.56%
ATAI	ATAI LIFE SCIENCES NV	$996.67M	-85.60%	-64.40%	-71.26%	-83.40%	0.32	4.02	100.00%	-5,171.20%	-5,050.97%
LCTX	LINEAGE CELL THERAPEUTICS INC	$308.28M	-60.20%	-39.70%	-51.11%	2,222.20%	0.90	4.08	97.60%	-374.80%	-374.84%
RNAC	CARTESIAN THERAPEUTICS INC	$254.09M	N/A	-10.30%	-9.65%	-20.90%	-19.78	12.34	100.00%	-124.40%	-111.27%
MLYS	MINERALYS THERAPEUTICS INC	$2.40B	-70.40%	-65.50%	-60.84%	-126.10%	0.07	15.12	N/A	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$1.06B	-106.30%	-87.90%	-108.80%	-160.80%	0.09	12.05	746.80%	17,205.70%	17,255.66%
ARVN	ARVINAS INC	$568.25M	-12.00%	-7.00%	-9.65%	-9.90%	0.49	5.64	100.00%	-19.50%	-19.45%
INSM	INSMED INC	$26.07B	-447.00%	-52.70%	-59.08%	-45.80%	17.18	5.86	76.50%	-265.90%	-242.45%
STRO	SUTRO BIOPHARMA INC	$75.00M	-347.60%	-59.50%	-116.00%	-133.70%	-13.45	2.16	100.00%	-369.10%	-328.94%
CDXS	CODEXIS INC	$220.25M	-105.80%	-46.10%	-44.00%	-37.20%	1.49	5.82	77.60%	-113.70%	-94.68%
ALT	ALTIMMUNE INC	$316.84M	-62.60%	-55.30%	-48.67%	-113.70%	0.18	20.44	100.00%	-584,973.30%	-587,700.00%
NRXP	NRX PHARMACEUTICALS INC	$59.12M	N/A	-658.10%	94.89%	181.50%	-1.14	0.11	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$195.57M	-93.80%	-75.70%	-90.98%	-101.70%	0.22	6.00	N/A	N/A	N/A
LENZ	LENZ THERAPEUTICS INC	$1.14B	-25.60%	-24.40%	-25.08%	-29.60%	0.05	20.54	100.00%	-1,048.00%	-1,037.94%
GLUE	MONTE ROSA THERAPEUTICS INC	$426.26M	2.70%	1.70%	2.83%	4.70%	0.43	5.61	100.00%	3.90%	5.93%
NRIX	NURIX THERAPEUTICS INC	$662.82M	-45.30%	-34.70%	-40.02%	-45.80%	0.32	6.82	100.00%	-234.60%	-233.61%
PASG	PASSAGE BIO INC	$22.09M	-103.90%	-59.90%	-95.72%	-105.40%	1.07	3.05	N/A	N/A	N/A
ANAB	ANAPTYSBIO INC	$564.42M	-367.00%	-30.60%	-44.21%	-20.90%	-8.49	8.22	100.00%	-107.70%	-107.59%
MBIO	MUSTANG BIO INC	$6.92M	N/A	-107.30%	-284.92%	103.30%	3.13	1.34	N/A	N/A	N/A
STTK	SHATTUCK LABS INC	$85.75M	-81.80%	-71.50%	-104.20%	-229.30%	0.13	10.25	100.00%	-2,052.50%	-2,052.52%
SION	SIONNA THERAPEUTICS INC	$984.76M	N/A	N/A	N/A	N/A	0.05	35.33	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$350.72M	-38.10%	-35.50%	-25.63%	734.90%	0.08	14.80	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$720.99M	N/A	-17.10%	-20.84%	-23.90%	-0.03	11.48	100.00%	-13,752.20%	-13,599.62%
CYTK	CYTOKINETICS INC	$5.90B	N/A	-43.70%	-52.14%	-29.40%	-5.75	5.99	100.00%	-3,201.50%	-2,996.11%
ICU	SEASTAR MEDICAL HOLDING CORP	$23.53M	N/A	-232.70%	-437.86%	393.00%	1.51	1.52	96.50%	-1,915.30%	-1,909.79%
ABCL	ABCELLERA BIOLOGICS INC	$1.30B	-15.70%	-12.20%	-16.60%	-19.30%	0.31	10.15	100.00%	-726.20%	-911.24%
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$89.15M	-51.10%	-45.70%	-64.16%	-278.10%	0.16	7.24	100.00%	-2,363.80%	-2,350.43%
INAB	IN8BIO INC	$9.08M	-183.10%	-125.50%	-137.16%	-226.60%	0.27	7.03	N/A	N/A	N/A
IVVD	INVIVYD INC	$153.78M	-177.90%	-91.00%	-246.45%	16,623.50%	1.08	1.33	93.40%	-238.30%	-238.33%
ACIU	AC IMMUNE SA	$249.02M	-49.00%	-23.10%	-55.17%	-112.50%	1.55	1.33	100.00%	-174.70%	-174.09%
ANIX	ANIXA BIOSCIENCES INC	$115.87M	-63.10%	-59.20%	-71.32%	-71.90%	0.14	8.45	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$9.84B	N/A	-87.60%	-70.83%	-29.80%	-1.60	5.19	96.20%	-329.30%	-271.62%
MREO	MEREO BIOPHARMA GROUP PLC	$280.01M	-80.00%	-66.90%	-91.42%	5,084.60%	0.16	8.13	73.60%	-9,910.00%	-10,070.00%
ADMA	ADMA BIOLOGICS INC	$3.65B	61.80%	42.90%	32.10%	37.00%	0.40	5.33	53.00%	44.10%	32.73%
VTGN	VISTAGEN THERAPEUTICS INC	$94.76M	-58.90%	-52.40%	-71.67%	-592.70%	0.20	6.51	100.00%	-10,579.80%	-10,578.40%
HYFT	MINDWALK HOLDINGS CORP	$81.23M	-114.30%	-61.20%	-134.12%	-119.00%	0.96	2.17	56.70%	-130.20%	-143.91%
CTMX	CYTOMX THERAPEUTICS INC	$160.44M	-553.10%	32.20%	86.63%	-811.10%	2.93	1.73	100.00%	28.20%	28.35%
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$61.65M	-201.50%	-95.30%	-130.90%	-179.20%	0.84	0.83	65.70%	-3,934.40%	-3,832.35%
DARE	DARE BIOSCIENCE INC	$27.36M	N/A	-103.70%	298.06%	201.40%	-2.02	0.34	-225.80%	105,099.60%	105,099.65%
GHRS	GH RESEARCH PLC	$813.19M	-16.70%	-16.10%	-13.28%	-54.40%	0.03	29.49	N/A	N/A	N/A
LIMN	LIMINATUS PHARMA INC	$48.13M	N/A	N/A	N/A	N/A	-1.31	0.23	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$176.90M	-132.50%	-92.80%	-99.82%	790.00%	0.24	4.91	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$2.15M	-47.60%	24.00%	15.19%	-57.90%	0.09	11.04	N/A	N/A	N/A
ONCY	ONCOLYTICS BIOTECH INC	$107.16M	-316.30%	-131.00%	-225.15%	8,462.00%	2.03	3.21	N/A	N/A	N/A
TLSA	TIZIANA LIFE SCIENCES LTD	$189.49M	-250.50%	-101.10%	-425.46%	-666.20%	1.87	1.02	N/A	N/A	N/A
CURX	CURANEX PHARMACEUTICALS INC	$233.93M	N/A	N/A	N/A	N/A	1.58	9.37	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$492.31M	-24.90%	-17.80%	-28.76%	-206.10%	0.34	5.90	100.00%	-49.30%	-61.89%
NEUP	NEUPHORIA THERAPEUTICS INC	$22.69M	N/A	N/A	N/A	N/A	0.18	11.01	N/A	N/A	N/A
NNNN	ANBIO BIOTECHNOLOGY	$6.05B	14.80%	13.70%	13.80%	44.90%	0.10	10.71	71.90%	29.00%	28.99%
TRVI	TREVI THERAPEUTICS INC	$982.13M	-41.40%	-38.20%	-23.78%	-68.40%	0.05	22.43	N/A	N/A	N/A
IMNM	IMMUNOME INC	$825.19M	-87.40%	-74.80%	-77.68%	-279.60%	0.10	12.13	100.00%	-1,687.10%	-1,687.08%
IKT	INHIBIKASE THERAPEUTICS INC	$119.23M	-63.80%	-58.00%	-51.85%	-319.40%	0.11	10.09	N/A	N/A	N/A
KURA	KURA ONCOLOGY INC	$710.78M	-43.60%	-29.10%	-27.22%	-36.40%	1.04	8.07	100.00%	-267.50%	-261.86%
PTGX	PROTAGONIST THERAPEUTICS INC	$3.63B	8.10%	7.40%	7.88%	10.00%	0.08	16.97	100.00%	24.90%	25.71%
GNLX	GENELUX CORP	$147.92M	-93.00%	-74.20%	-94.30%	-115.30%	0.31	4.68	N/A	N/A	N/A
QURE	UNIQURE NV	$813.95M	-1,010.70%	-33.30%	-24.83%	-18.20%	-147.11	9.98	82.60%	-1,388.00%	-942.05%
ALMS	ALUMIS INC	$455.80M	-72.10%	-56.00%	-44.94%	-116.10%	0.26	6.05	100.00%	-1,134.50%	-1,177.16%
ALDX	ALDEYRA THERAPEUTICS INC	$304.87M	-73.60%	-50.60%	-87.88%	-115.80%	0.54	2.86	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$19.39M	-62.80%	-33.70%	-51.63%	-60.40%	0.92	0.48	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$170.42M	-71.60%	-57.00%	-85.55%	-63.50%	0.33	6.66	100.00%	-2,427.10%	-2,427.19%
LQDA	LIQUIDIA CORP	$2.30B	-223.90%	-58.50%	-69.15%	-84.80%	15.95	2.49	69.30%	-732.20%	-640.62%
XLO	XILIO THERAPEUTICS INC	$38.97M	-399.20%	-58.70%	-69.80%	263.80%	17.93	2.32	100.00%	-374.80%	-374.79%
TVRD	TVARDI THERAPEUTICS INC	$316.58M	-398.60%	-47.00%	-41.86%	-35.80%	0.33	4.04	100.00%	-317.50%	-210.40%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$104.60M	-51.60%	-40.30%	-52.13%	-46.30%	0.28	7.99	100.00%	401.30%	401.91%
GLPG	GALAPAGOS NV	$2.10B	N/A	N/A	N/A	N/A	0.44	8.08	N/A	N/A	N/A
LBRX	LB PHARMACEUTICALS INC	N/A	N/A	N/A	N/A	N/A	-0.09	3.78	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$50.54M	-129.60%	-57.30%	-73.96%	1,572.10%	1.67	9.35	N/A	N/A	N/A
IFRX	INFLARX NV	$83.33M	-71.30%	-57.30%	-79.02%	-117.80%	0.29	4.10	-3,067.30%	-27,815.70%	-27,802.02%
ACOG	ALPHA COGNITION INC	$152.72M	-72.00%	-53.60%	-47.34%	-5,948.70%	0.42	14.69	70.10%	-436.40%	-434.42%
AUTL	AUTOLUS THERAPEUTICS PLC	$351.31M	-56.20%	-29.60%	-36.84%	-33.00%	1.08	8.43	-79.70%	-760.90%	-803.46%
FATE	FATE THERAPEUTICS INC	$110.26M	-55.70%	-40.20%	-50.01%	-39.90%	0.42	8.04	100.00%	-2,025.10%	-2,025.05%
MCRB	SERES THERAPEUTICS INC	$137.36M	283.90%	54.90%	76.17%	59.00%	3.36	1.57	N/A	N/A	N/A
UPB	UPSTREAM BIO INC	$905.14M	-37.80%	-27.70%	-25.51%	-38.70%	0.03	38.27	100.00%	-4,041.80%	-3,836.58%
PYXS	PYXIS ONCOLOGY INC	$117.83M	-82.80%	-63.00%	-93.02%	-74.20%	0.41	5.65	100.00%	-3,414.40%	-3,481.10%
FGEN	FIBROGEN INC	$47.88M	N/A	-1.00%	2.42%	0.40%	-1.61	1.04	79.40%	2.80%	-0.74%
APVO	APTEVO THERAPEUTICS INC	$4.73M	-675.50%	-175.70%	-223.84%	-428.90%	1.40	2.27	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$924.32M	-59.20%	-50.60%	-73.70%	-252.80%	0.22	5.23	100.00%	-1,180.00%	-1,178.41%
VTYX	VENTYX BIOSCIENCES INC	$164.01M	-48.90%	-44.90%	-54.46%	-52.80%	0.10	19.12	N/A	N/A	N/A
ABVX	ABIVAX SA	$5.45B	-499.80%	-96.70%	-2,429.06%	-391.00%	-3.48	0.77	100.00%	-2,530.60%	-2,293.15%
DNA	GINKGO BIOWORKS HOLDINGS INC	$601.12M	-63.10%	-32.70%	-40.11%	-41.90%	1.00	4.88	80.00%	-198.80%	-198.98%
TLX	TELIX PHARMACEUTICALS LTD	$3.18B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
RAPP	RAPPORT THERAPEUTICS INC	$902.59M	-30.00%	-28.60%	-32.28%	-35.00%	0.08	22.75	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$1.20B	-58.70%	-46.30%	-60.20%	-51.60%	0.26	4.90	100.00%	-1,154.10%	-1,154.10%
NLSP	NLS PHARMACEUTICS LTD	$6.86M	N/A	-198.90%	-130.18%	65.40%	0.59	2.69	N/A	N/A	N/A
RAPT	RAPT THERAPEUTICS INC	$287.98M	-81.50%	-70.20%	-65.13%	-157.70%	0.06	21.11	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 16 points higher than the biotech industry average of 23.

TBPH passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.34% over the past year, overperforming other biotech stocks by 127 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 78.24% from Theravance Biopharma's current stock price of $14.40.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #2 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 40, which is 17 points higher than the biotech industry average of 23.

RIGL passed 13 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 171.27% over the past year, overperforming other biotech stocks by 221 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $32.00, a downside of -14.21% from Rigel Pharmaceuticals's current stock price of $37.30.

Rigel Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Rigel Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #3 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: D, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 12, which is -11 points lower than the biotech industry average of 23. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 4 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -2.65% over the past year, overperforming other biotech stocks by 47 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $17.13, an upside of 122.4% from Biocryst Pharmaceuticals's current stock price of $7.70.

Biocryst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Biocryst Pharmaceuticals, 37.5% have issued a Strong Buy rating, 50% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Essa Pharma (NASDAQ:EPIX)

Essa Pharma (NASDAQ:EPIX) has an annual dividend yield of 880.74%, which is 753 percentage points higher than the biotech industry average of 127.91%.

Essa Pharma's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 9.11%, which is -119 percentage points lower than the biotech industry average of 127.91%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.48%, which is -125 percentage points lower than the biotech industry average of 127.91%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.46% in the last day, and down -1.01% over the last week. Atyr Pharma was the among the top losers in the biotechnology industry, dropping -83.17% yesterday.

aTyr Pharma shares are trading lower after the company announced topline results from its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.15% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 84.13% in the past year. It has overperformed other stocks in the biotech industry by 134 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has gained 25.19% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

55.4% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 81.39% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.43% of biotech stocks are rated B (Buy), 41.98% are rated C (Hold), 35.44% are rated D (Sell), and 16.03% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -100.7x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.